Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Insights Into the Evolution of Staphylococcus aureus Daptomycin Resistance From an in vitro Bioreactor Model.

Lasek-Nesselquist E, Lu J, Schneider R, Ma Z, Russo V, Mishra S, Pai MP, Pata JD, McDonough KA, Malik M.

Front Microbiol. 2019 Feb 28;10:345. doi: 10.3389/fmicb.2019.00345. eCollection 2019.

2.

Role of peroxiredoxin of the AhpC/TSA family in antioxidant defense mechanisms of Francisella tularensis.

Alharbi A, Rabadi SM, Alqahtani M, Marghani D, Worden M, Ma Z, Malik M, Bakshi CS.

PLoS One. 2019 Mar 14;14(3):e0213699. doi: 10.1371/journal.pone.0213699. eCollection 2019.

3.

An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia.

Mansour AA, Banik S, Suresh RV, Kaur H, Malik M, McCormick AA, Bakshi CS.

Front Microbiol. 2018 Jun 5;9:1195. doi: 10.3389/fmicb.2018.01195. eCollection 2018.

4.

Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.

Ma Z, Lasek-Nesselquist E, Lu J, Schneider R, Shah R, Oliva G, Pata J, McDonough K, Pai MP, Rose WE, Sakoulas G, Malik M.

PLoS One. 2018 Jun 7;13(6):e0198366. doi: 10.1371/journal.pone.0198366. eCollection 2018.

5.

Characterization of a Unique Outer Membrane Protein Required for Oxidative Stress Resistance and Virulence of Francisella tularensis.

Alqahtani M, Ma Z, Ketkar H, Suresh RV, Malik M, Bakshi CS.

J Bacteriol. 2018 Mar 26;200(8). pii: e00693-17. doi: 10.1128/JB.00693-17. Print 2018 Apr 15.

6.

Necroptotic debris including damaged mitochondria elicits sepsis-like syndrome during late-phase tularemia.

Singh A, Periasamy S, Malik M, Bakshi CS, Stephen L, Ault JG, Mannella CA, Sellati TJ.

Cell Death Discov. 2017 Sep 25;3:17056. doi: 10.1038/cddiscovery.2017.56. eCollection 2017.

7.

Elucidation of a mechanism of oxidative stress regulation in Francisella tularensis live vaccine strain.

Ma Z, Russo VC, Rabadi SM, Jen Y, Catlett SV, Bakshi CS, Malik M.

Mol Microbiol. 2016 Sep;101(5):856-78. doi: 10.1111/mmi.13426. Epub 2016 Jun 16.

8.

Antioxidant Defenses of Francisella tularensis Modulate Macrophage Function and Production of Proinflammatory Cytokines.

Rabadi SM, Sanchez BC, Varanat M, Ma Z, Catlett SV, Melendez JA, Malik M, Bakshi CS.

J Biol Chem. 2016 Mar 4;291(10):5009-21. doi: 10.1074/jbc.M115.681478. Epub 2015 Dec 7.

9.

Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.

Banik S, Mansour AA, Suresh RV, Wykoff-Clary S, Malik M, McCormick AA, Bakshi CS.

PLoS One. 2015 Jun 22;10(6):e0130858. doi: 10.1371/journal.pone.0130858. eCollection 2015.

10.

Preclinical testing of a vaccine candidate against tularemia.

Suresh RV, Ma Z, Sunagar R, Bhatty V, Banik S, Catlett SV, Gosselin EJ, Malik M, Bakshi CS.

PLoS One. 2015 Apr 21;10(4):e0124326. doi: 10.1371/journal.pone.0124326. eCollection 2015.

11.

EmrA1 membrane fusion protein of Francisella tularensis LVS is required for resistance to oxidative stress, intramacrophage survival and virulence in mice.

Ma Z, Banik S, Rane H, Mora VT, Rabadi SM, Doyle CR, Thanassi DG, Bakshi CS, Malik M.

Mol Microbiol. 2014 Mar;91(5):976-95. doi: 10.1111/mmi.12509. Epub 2014 Feb 8.

12.

Repression of inflammasome by Francisella tularensis during early stages of infection.

Dotson RJ, Rabadi SM, Westcott EL, Bradley S, Catlett SV, Banik S, Harton JA, Bakshi CS, Malik M.

J Biol Chem. 2013 Aug 16;288(33):23844-57. doi: 10.1074/jbc.M113.490086. Epub 2013 Jul 2.

13.

Identification of a live attenuated vaccine candidate for tularemia prophylaxis.

Mahawar M, Rabadi SM, Banik S, Catlett SV, Metzger DW, Malik M, Bakshi CS.

PLoS One. 2013 Apr 17;8(4):e61539. doi: 10.1371/journal.pone.0061539. Print 2013.

14.

Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity.

Singh A, Rahman T, Malik M, Hickey AJ, Leifer CA, Hazlett KR, Sellati TJ.

PLoS One. 2013;8(3):e58513. doi: 10.1371/journal.pone.0058513. Epub 2013 Mar 12.

15.

Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response.

Mahawar M, Atianand MK, Dotson RJ, Mora V, Rabadi SM, Metzger DW, Huntley JF, Harton JA, Malik M, Bakshi CS.

J Biol Chem. 2012 Jul 20;287(30):25216-29. doi: 10.1074/jbc.M112.367672. Epub 2012 May 31.

16.

Modeling of permeabilization process in Pseudomonas putida G7 for enhanced limonin bioconversion.

Malik M, Ganguli A, Ghosh M.

Appl Microbiol Biotechnol. 2012 Jul;95(1):223-31. doi: 10.1007/s00253-012-3880-z. Epub 2012 Apr 11.

PMID:
22526774
17.

Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation.

Atianand MK, Duffy EB, Shah A, Kar S, Malik M, Harton JA.

J Biol Chem. 2011 Nov 11;286(45):39033-42. doi: 10.1074/jbc.M111.244079. Epub 2011 Sep 19.

18.

Enhancement of bioconversion efficiency of limonin by Pseudmonas putida G7.

Malik M, Ganguli A, Ghosh M.

Int J Food Sci Nutr. 2012 Feb;63(1):59-65. doi: 10.3109/09637486.2011.596823. Epub 2011 Jul 6.

PMID:
21732728
19.

GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophages.

Noah CE, Malik M, Bublitz DC, Camenares D, Sellati TJ, Benach JL, Furie MB.

Infect Immun. 2010 Apr;78(4):1797-806. doi: 10.1128/IAI.01135-09. Epub 2010 Feb 1.

20.

Identification of Francisella tularensis live vaccine strain CuZn superoxide dismutase as critical for resistance to extracellularly generated reactive oxygen species.

Melillo AA, Mahawar M, Sellati TJ, Malik M, Metzger DW, Melendez JA, Bakshi CS.

J Bacteriol. 2009 Oct;191(20):6447-56. doi: 10.1128/JB.00534-09. Epub 2009 Aug 14.

Supplemental Content

Loading ...
Support Center